...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Your thoughts please
4
Sep 04, 2024 12:17AM
5
Sep 04, 2024 09:22AM
6
Sep 04, 2024 01:00PM
7
Sep 04, 2024 01:15PM
7
Sep 04, 2024 02:28PM
8
Sep 05, 2024 02:32PM
9
Sep 07, 2024 10:34PM
3
Sep 08, 2024 07:30AM
4
Sep 08, 2024 07:59AM
8
Sep 08, 2024 08:42AM
7
Sep 08, 2024 02:00PM
1
Sep 09, 2024 02:05AM
8
Sep 09, 2024 07:59AM
2
Sep 09, 2024 11:53AM
2
Sep 09, 2024 12:24PM
4
Sep 09, 2024 03:08PM

Good question for cityslicker?

NUT Carcinoma is a good opportunity for fast tracking if the ORR stays so impressive, since there is no cure and such short survival after diagnosis ... our ORR is great so far, and our safety profile is so strong.

One approval could really help open the door for ABL (with BTD) also, if Don can actually prove his bag of magic beans are really magic, and get BoM2 financed. 

On paper it looks like a long slog remaining for ABL potentially, under current strategy and if the NUT has to do a full P3 - 5-8 years possibly? Unless Zenith success and proof of concept can accelerate a full sale, or help accelerate BoM2 to a quicker and shorter P3 success. 

Just sooo much can happen along the way also, as data continues to advance and come together, and if the BP's that are paying attention get itchy competitive trigger fingers, as the results and story grows.

4
Sep 09, 2024 04:56PM
4
Sep 10, 2024 06:15AM
2
Sep 10, 2024 11:25AM
6
Sep 10, 2024 11:51AM
3
Sep 10, 2024 12:46PM
Share
New Message
Please login to post a reply